Compare Adaptive Biotechnologies Corp (ADPT) vs Zoom Video Communications, Inc. (ZM) Price & Performance

ADPT trades at $20.82, down 1.75% today, with a bullish technical signal from moving averages and a consensus analyst price target of $20.40. The company announced a strategic separation of its MRD and Immune Medicine businesses in June 2026, alongside a $300 million convertible notes offering to enhance financial flexibility. Revenue grew to $277 million in 2025, though net losses persist at -$59.50 million, with improving margins and cash flow trends showing net positive cash generation of $22.37 million.

Outlook remains cautiously optimistic as the business split aims to unlock value, but execution risks and sustained profitability challenges pose headwinds. Analysts are predominantly bullish (64.71% buy ratings), citing growth in the clonoSEQ MRD segment, yet the stock faces volatility from high valuation multiples and insider selling activity.

Zoom Communications (ZM) trades at $85.68, down 1.68% on the day, with a bearish technical outlook despite strong fundamentals. The stock shows robust profitability with 77.4% gross margins and 42% net income margin, while trading at attractive valuation multiples (P/E 12.5x, P/S 5.2x). Recent Q1 2026 earnings beat expectations, and the company continues AI-driven growth through acquisitions like Common Room and new product launches.

ZM presents a compelling value opportunity with significant upside to the $118.79 consensus price target, though technical weakness and competitive pressures from Microsoft and Google remain headwinds. The company's strong cash position ($7.7B) and strategic Anthropic investment provide additional upside catalysts, making it attractive for patient investors despite near-term bearish technical signals.